DATA GRAPHICS | Data Byte
Biosecure Act’s advance sinks shares of two WuXi entities
Passage of bill targeting Chinese CDMOs dents WuXi AppTec, WuXi Biologics stocks
September 11, 2024 12:23 AM UTC
The latest lurch forward by the Biosecure Act in Congress had the predictable result of weighing on shares of Chinese CDMOs and genomics companies, with WuXi AppTec hardest hit.
Shares of WuXi AppTec Co. Ltd. (Shanghai:603259; HKEX:2359) sank 10%, and WuXi Biologics Inc. (HKEX:2269) fell 4%, after the Biosecure Act passed the U.S. House of Representatives on Monday in a 306 to 81 vote. Both stocks finished near 52-week lows...